| --- | --- | --- | |----------------------------------------------------------|-------|-------| | | | | | Halozyme Therapeutics, Inc. | | | | Fourth Quarter and FY 2023 Financial & Operating Results | | | | | | | | NASDAQ: HALO | | | | February 20, 2024 | | | | | | | In addition to historical information, the statements set forth in this presentation include forward-looking statements including, without limitation, statements concerning the Company's expected future growth, financial performance (including ...